OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong
· Delayed Price · Currency is HKD 3.740
-0.080 (-2.09%)
May 9, 2025, 3:52 PM HKT
HKG:6929 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 164.1 | 153.87 | 136.82 | 116.46 | 88.47 | Upgrade
|
| Revenue Growth (YoY) | 6.65% | 12.46% | 17.48% | 31.64% | -8.17% | Upgrade
|
| Cost of Revenue | 49.63 | 47.37 | 44.37 | 35.29 | 30.45 | Upgrade
|
| Gross Profit | 114.47 | 106.5 | 92.46 | 81.17 | 58.02 | Upgrade
|
| Selling, General & Admin | 62.7 | 54.84 | 55.13 | 50.06 | 41.11 | Upgrade
|
| Research & Development | 17.05 | 14.38 | 14.11 | 12.15 | 12.46 | Upgrade
|
| Other Operating Expenses | -0.44 | -2.14 | -0.92 | -1.4 | -2.4 | Upgrade
|
| Operating Expenses | 79.65 | 67.14 | 68.57 | 60.7 | 50.24 | Upgrade
|
| Operating Income | 34.82 | 39.36 | 23.89 | 20.48 | 7.78 | Upgrade
|
| Interest Expense | -0.22 | -0.13 | -1.46 | -5.61 | -1.4 | Upgrade
|
| Interest & Investment Income | 11.92 | 10.67 | 2.39 | 0.01 | 0.01 | Upgrade
|
| Earnings From Equity Investments | -1.51 | -0.84 | -0.2 | -0.21 | -0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.71 | -0.36 | -0.97 | -0.9 | 1.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0.01 | -0.01 | -0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | 44.3 | 48.69 | 23.65 | 13.77 | 7.36 | Upgrade
|
| Impairment of Goodwill | -1.57 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.28 | 0.98 | -1.49 | -0.05 | -0.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -0.05 | -0.03 | -0.08 | 0.01 | Upgrade
|
| Asset Writedown | - | - | -0.34 | - | - | Upgrade
|
| Other Unusual Items | -0.03 | 0.01 | 0 | -14.96 | - | Upgrade
|
| Pretax Income | 42.41 | 49.63 | 21.79 | -1.32 | 7.26 | Upgrade
|
| Income Tax Expense | 2.56 | 4.56 | 3.3 | 3.13 | 0.18 | Upgrade
|
| Earnings From Continuing Operations | 39.85 | 45.07 | 18.49 | -4.44 | 7.07 | Upgrade
|
| Minority Interest in Earnings | -0.13 | - | - | - | - | Upgrade
|
| Net Income | 39.72 | 45.07 | 18.49 | -4.44 | 7.07 | Upgrade
|
| Net Income to Common | 39.72 | 45.07 | 18.49 | -4.44 | 7.07 | Upgrade
|
| Net Income Growth | -11.88% | 143.76% | - | - | 1.62% | Upgrade
|
| Shares Outstanding (Basic) | 826 | 828 | 583 | 577 | 577 | Upgrade
|
| Shares Outstanding (Diluted) | 826 | 833 | 776 | 577 | 577 | Upgrade
|
| Shares Change (YoY) | -0.80% | 7.29% | 34.58% | - | - | Upgrade
|
| EPS (Basic) | 0.05 | 0.05 | 0.03 | -0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.05 | 0.03 | -0.01 | 0.01 | Upgrade
|
| EPS Growth | -11.09% | 111.85% | - | - | 2.13% | Upgrade
|
| Free Cash Flow | 3.32 | 17.43 | 20.53 | 19.25 | 11.72 | Upgrade
|
| Free Cash Flow Per Share | 0.00 | 0.02 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Dividend Per Share | 0.013 | 0.013 | - | - | - | Upgrade
|
| Gross Margin | 69.76% | 69.22% | 67.57% | 69.70% | 65.58% | Upgrade
|
| Operating Margin | 21.22% | 25.58% | 17.46% | 17.58% | 8.80% | Upgrade
|
| Profit Margin | 24.20% | 29.29% | 13.51% | -3.82% | 7.99% | Upgrade
|
| Free Cash Flow Margin | 2.02% | 11.33% | 15.01% | 16.53% | 13.25% | Upgrade
|
| EBITDA | 37.61 | 41.3 | 25.84 | 22.86 | 10.3 | Upgrade
|
| EBITDA Margin | 22.92% | 26.84% | 18.89% | 19.63% | 11.64% | Upgrade
|
| D&A For EBITDA | 2.79 | 1.94 | 1.95 | 2.39 | 2.52 | Upgrade
|
| EBIT | 34.82 | 39.36 | 23.89 | 20.48 | 7.78 | Upgrade
|
| EBIT Margin | 21.22% | 25.58% | 17.46% | 17.58% | 8.80% | Upgrade
|
| Effective Tax Rate | 6.04% | 9.18% | 15.14% | - | 2.54% | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.